NCT05769777 · Interventional trial
Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Overall registry status Active not recruiting
Phase 2
Conditions Dermatitis Atopic
Delaware Valley sites
- The Children's Hospital of Philadelphia- Site Number : 8400009 · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory